Thrombocytopenia Immune-related (ITP): Characteristics and origins

Thrombocytopenia Immune-related (ITP): Characteristics and origins

Immune Thrombocytopenia (ITP), a condition characterized by a lack of platelets in the body, can lead to an increased risk of excessive bleeding. This article aims to provide a comprehensive overview of ITP, its causes, symptoms, and treatment options.

Causes of ITP

ITP can occur on its own (primary ITP) or as a result of another medical condition (secondary ITP). Secondary ITP can be caused by autoimmune diseases, persistent infections, lymphoproliferative disorders, or the presence of Helicobacter pylori bacteria.

In some cases, a family history or genetics with mutations or changes in the genes that control platelet production can lead to ITP. Certain medications, such as heparin and quinidine, can also induce thrombocytopenia that resembles ITP.

Secondary autoimmune diseases, persistent infections, and cancers that can cause a condition similar to ITP include systemic lupus erythematosus (SLE), antiphospholipid syndrome, HIV, hepatitis C, and lymphoproliferative disorders (such as lymphomas).

Symptoms of ITP

ITP can cause symptoms such as petechiae (small red or purple spots on the skin), purpura (larger bruise-like spots), bruising, nosebleeds, bleeding from the gums, heavy menstrual bleeding, gastrointestinal bleeding, and extreme tiredness.

Diagnosis and Treatment of ITP

Diagnosing ITP involves taking a full medical history, blood tests to check electrolyte levels, kidney and liver function, platelet levels, and tests to assess bone marrow function. A doctor may also suggest certain lifestyle changes to help manage ITP, such as eating a balanced diet, limiting alcohol, quitting smoking, avoiding aspirin and NSAIDs, avoiding activities with a high risk of injury, having regular dental care, and practicing oral hygiene.

Treatment options for ITP include corticosteroids, immunoglobulins, Rituximab (Rituxan), thrombopoietin receptor agonists, platelet or whole blood transfusions, and in severe cases, a splenectomy. Living without a spleen increases the risk of bacterial infections and can increase illness severity.

Prevalence of ITP

ITP is more prevalent in older adults aged 60 years and over and in children under 10 years. In children, secondary ITP often develops after a viral infection, including chickenpox, common cold, or COVID-19.

Risk Factors for ITP

Lifestyle habits such as drinking alcohol, using tobacco, eating walnuts, sesame seeds, and certain medications can increase the risk of ITP. Females are more likely to develop ITP than males. Health conditions like HIV-associated disease, vitamin B12 deficiency, anemia, blood and bone marrow diseases, kidney disease, liver disease may increase the risk of ITP.

Rare Cases

Rarely, ITP can develop after a vaccination, such as the MMR or COVID-19 vaccine, but this is very unlikely. In ITP, bone marrow is usually normal.

Conclusion

ITP is a complex condition that requires careful diagnosis and management. Understanding the causes, symptoms, and treatment options is essential for those affected by ITP and their healthcare providers. It is important to remember that ITP is a diagnosis of exclusion, where doctors rule out other potential causes of low platelet counts before arriving at the ITP diagnosis.

1. Science has provided insights into the causes of Immune Thrombocytopenia (ITP), revealing that it can occur due to autoimmune diseases, persistent infections, certain medications, or genetic mutations.
2. In addition to ITP, chronic diseases like systemic lupus erythematosus (SLE), antiphospholipid syndrome, HIV, hepatitis C, and lymphomas can lead to a condition similar to ITP.
3. Health-and-wellness practices play a crucial role in the management of ITP, as a balanced diet, quitting smoking, and regular dental care can help alleviate symptoms.
4. Medicare and therapies-and-treatments such as corticosteroids, immunoglobulins, Rituximab (Rituxan), thrombopoietin receptor agonists, platelet or whole blood transfusions, and in severe cases, a splenectomy, are utilized to treat ITP.
5. Mental-health, women's-health, and men's-health providers should be aware of ITP, given its prevalence in older adults and children, as well as its increased occurrence in females.
6. With the rise of alternative treatments like CBD, further studies are needed to determine its potential role in managing the symptoms and complications associated with ITP.

Read also: